As of 2025-04-29, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 1.51 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -6.68 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 7.2x | 5.8x |
| Forward P/E multiples | 1.1x - 2.3x | 1.7x |
| Fair Price | (0.24) - (0.13) | (0.21) |
| Upside | -1704.2% - -942.8% | -1474.7% |
| Date | EV/EBITDA |
| 2025-04-01 | -0.23 |
| 2025-03-28 | -0.23 |
| 2025-03-24 | -0.23 |
| 2025-03-20 | -0.31 |
| 2025-03-18 | -0.31 |
| 2025-02-04 | -0.31 |
| 2025-01-31 | -0.23 |
| 2025-01-29 | -0.40 |